Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,674,000 | 6,064,000 | 5,875,000 | 7,363,000 | 13,023,000 |
| Marketable Securities | 773,000 | N/A | N/A | N/A | 839,000 |
| Receivables | 8,180,000 | 8,495,000 | 8,750,000 | 8,794,000 | 8,275,000 |
| Inventories | 6,226,000 | 6,562,000 | 6,614,000 | 6,271,000 | 6,093,000 |
| Other current assets | 2,992,000 | 2,924,000 | 3,507,000 | 3,282,000 | 9,331,000 |
| TOTAL | $22,845,000 | $24,045,000 | $24,746,000 | $25,710,000 | $37,561,000 |
| Non-Current Assets | |||||
| PPE Net | 15,982,000 | 15,796,000 | 15,870,000 | 15,421,000 | 15,983,000 |
| Investments And Advances | 17,780,000 | 0 | 0 | 0 | 10,152,000 |
| Intangibles | 65,391,000 | 66,014,000 | 67,228,000 | 67,331,000 | 53,143,000 |
| Other Non-Current Assets | 9,558,000 | 27,072,000 | 27,569,000 | 26,473,000 | 8,548,000 |
| TOTAL | $108,711,000 | $108,882,000 | $110,667,000 | $109,225,000 | $87,826,000 |
| Total Assets | $131,556,000 | $132,927,000 | $135,413,000 | $134,935,000 | $125,387,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,604,000 | 9,289,000 | 9,973,000 | 10,279,000 | 6,612,000 |
| Accounts payable and accrued liabilities | 5,668,000 | 4,825,000 | 5,126,000 | 5,062,000 | 5,419,000 |
| Other current liabilities | 10,719,000 | 14,044,000 | 14,068,000 | 13,487,000 | 10,448,000 |
| TOTAL | $23,708,000 | $28,158,000 | $29,389,000 | $29,053,000 | $26,973,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,327,000 | 13,412,000 | 13,301,000 | 14,834,000 | 13,799,000 |
| Other Non-Current Liabilities | 8,042,000 | 14,565,000 | 13,889,000 | 14,604,000 | 7,676,000 |
| TOTAL | $30,726,000 | $27,984,000 | $27,192,000 | $29,438,000 | $27,570,000 |
| Total Liabilities | $54,434,000 | $56,142,000 | $56,581,000 | $58,491,000 | $54,543,000 |
| Shareholders' Equity | |||||
| Common Shares | 991,000 | N/A | N/A | N/A | 1,001,000 |
| Retained earnings | 76,156,000 | N/A | N/A | N/A | 69,868,000 |
| Other shareholders' equity | 76,000 | 76,785,000 | 78,832,000 | 76,444,000 | 78,000 |
| TOTAL | $77,122,000 | $76,785,000 | $78,832,000 | $76,444,000 | $70,844,000 |
| Total Liabilities And Equity | $131,556,000 | $132,927,000 | $135,413,000 | $134,935,000 | $125,387,000 |